Sign In
Buy FTXH
$34.53
+0.573 (+1.69%)
At Close: Jun 03, 2026
Can Health Care Stocks Outperform Again In 2023?
06:09pm, Wednesday, 11'th Jan 2023
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
5 Best Sector ETFs of 2022
02:18pm, Wednesday, 14'th Dec 2022
Here are the top-performing sector ETFs of 2022. These include energy, healthcare, materials, utilities and consumer staples.
Amgen to Buy Horizon Therapeutics: ETFs to Bet On
12:48pm, Tuesday, 13'th Dec 2022
Amgen (AMGN) has agreed to buy Horizon Therapeutics PLC (HZNP) for $27.8 billion. This put the spotlight on pharma ETFs, which could be the best way for investors to tap the opportunity arising from t
2 Sector ETFs Hovering Around a 52-Week High
02:18pm, Tuesday, 06'th Dec 2022
We all know that Wall Street is shattered this year. Still, two sectors -- Biotech and Aerospace -- have recently hit a 52-week high.
Pharma ETFs in Focus Post Q3 Earnings
12:47pm, Wednesday, 09'th Nov 2022
The Q3 earnings picture for the healthcare sector seems solid, with results from companies that have reported so far up 2.1% on 5.8% revenue growth.
Pharma ETFs in Focus Post Q1 Earnings
12:48pm, Thursday, 12'th May 2022
Many industry bigwigs reported solid results with some beating on earnings or revenues or both.
Pharma In Transition: Context And Opportunities
02:32pm, Monday, 28'th Mar 2022
The pending separation of consumer care businesses by pharmaceutical companies is understandable and may offer investment opportunities.
Solid Q4 Earnings Fail to Impress Pharma ETFs
01:50pm, Tuesday, 22'nd Feb 2022
Solid earnings failed to impress pharma ETFs over the past month due to a broad sell-off in the market.
Wave of Solid Q3 Earnings Push Pharma ETFs Higher
11:28am, Tuesday, 09'th Nov 2021
The slew of Q3 results has led to smooth trading in pharma ETFs over the past month.
Pharma ETFs Gain on Q2 Earnings
11:30am, Friday, 06'th Aug 2021
Many industry bigwigs reported solid results with some beating on earnings or revenues or both.
Pharma ETFs in Focus Post Q1 Earnings
12:47pm, Wednesday, 12'th May 2021
The slew of Q1 results have led to mixed trading in pharma ETFs over the past month.
Biotech Innovations Remain At Forefront
11:10am, Friday, 16'th Apr 2021
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r
Moving Beyond COVID In Biopharma
09:31am, Thursday, 15'th Apr 2021
Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12,
ETFs to Shine on Pfizer's Impressive COVID-19 Vaccine Update
06:12pm, Wednesday, 31'st Mar 2021
Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development as the outbreak worsens.
Healthcare: A Wide Choice Of Large And Well-Established Companies
02:41am, Friday, 19'th Feb 2021
The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets
